Canada markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5900+0.0500 (+3.25%)
At close: 04:00PM EDT
1.6000 +0.01 (+0.63%)
After hours: 07:26PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 25.30M
Enterprise Value 20.32M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.03
Enterprise Value/Revenue 105.22
Enterprise Value/EBITDA -0.59

Trading Information

Stock Price History

Beta (5Y Monthly) 2.36
52-Week Change 335.40%
S&P500 52-Week Change 323.10%
52 Week High 32.5000
52 Week Low 30.6220
50-Day Moving Average 31.5203
200-Day Moving Average 31.3087

Share Statistics

Avg Vol (3 month) 3205.2k
Avg Vol (10 day) 3129.57k
Shares Outstanding 516.43M
Implied Shares Outstanding 616.43M
Float 815.34M
% Held by Insiders 11.50%
% Held by Institutions 17.51%
Shares Short (Apr 15, 2024) 41.2M
Short Ratio (Apr 15, 2024) 47.09
Short % of Float (Apr 15, 2024) 47.42%
Short % of Shares Outstanding (Apr 15, 2024) 47.29%
Shares Short (prior month Mar 15, 2024) 41.21M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 18, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-63.74%
Return on Equity (ttm)-355.35%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -45.72M
Net Income Avi to Common (ttm)-38.37M
Diluted EPS (ttm)-2.9600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.93M
Total Cash Per Share (mrq)1.46
Total Debt (mrq)19.51M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.89
Book Value Per Share (mrq)-0.47

Cash Flow Statement

Operating Cash Flow (ttm)-39.33M
Levered Free Cash Flow (ttm)-22.38M